CM
Caption Management Portfolio holdings
AUM
$21.5B
Turnover
58.11%
1-Year Est. Return
81.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.74%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
+$2.54B
(+17%)
Cap. Flow
-$40.7M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,194
New
682
Increased
333
Reduced
357
Closed
710
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OWL
|
+$166M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.1M |
| 3 |
NVIDIA
NVDA
|
+$63.6M |
| 4 |
Take-Two Interactive
TTWO
|
+$56.8M |
| 5 |
Global X Cybersecurity ETF
BUG
|
+$23.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$128M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$124M |
| 3 |
Netflix
NFLX
|
+$48.3M |
| 4 |
Microsoft
MSFT
|
+$33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 88.8% |
| 2 | Technology | 2.44% |
| 3 | Healthcare | 2.37% |
| 4 | Consumer Discretionary | 1.9% |
| 5 | Financials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
PUT
Ultragenyx Pharmaceutical
RARE
$1.47B
| $6.08M | 0.04% |
290,000
-114,700
| -28% | -$2.58M |
2024 Q3
6 quarters
|
|
477
CALL
Robinhood
HOOD
$90.9B
| $6.06M | 0.04% |
+87,500
| New | +$7.68M |
2026 Q1
0 quarters
|
|
478
PUT
DELISTED
Day One Biopharmaceuticals
DAWN
| $6.06M | 0.04% |
282,500
+257,500
| +1,030% | +$3.63M |
2025 Q4
1 quarter
|
|
479
CALL
Karyopharm Therapeutics
KPTI
$7.14M
| $6.05M | 0.04% |
+1,086,900
| New | +$8.29M |
2026 Q1
0 quarters
|
|
480
CALL
Visa
V
$735B
| $6.04M | 0.04% |
+20,000
| New | +$6.43M |
2026 Q1
0 quarters
|
|
481
CALL
Vericel Corp
VCEL
$2.06B
| $6.03M | 0.04% |
+187,500
| New | +$6.66M |
2026 Q1
0 quarters
|
|
|
482
PUT
Vericel Corp
VCEL
$2.06B
| $6.03M | 0.04% |
+187,500
| New | +$6.66M |
2026 Q1
0 quarters
|
|
483
Chemours
CC
$1.93B
| $5.97M | 0.03% |
+270,800
| New | +$4.71M |
2026 Q1
0 quarters
|
|
484
ADMA Biologics
ADMA
$2.32B
| $5.95M | 0.03% |
+660,000
| New | +$10.4M |
2026 Q1
0 quarters
|
|
485
CALL
Herbalife
HLF
$1.49B
| $5.89M | 0.03% |
400,000
+346,300
| +645% | +$5.66M |
2025 Q4
1 quarter
|
|
486
PUT
DELISTED
ProAssurance
PRA
| $5.86M | 0.03% |
+237,000
| New | +$5.78M |
2026 Q1
0 quarters
|
|
487
CALL
Zoom
ZM
$27.6B
| $5.85M | 0.03% |
+72,800
| New | +$6.1M |
2026 Q1
0 quarters
|
|
488
PUT
Precigen
PGEN
$2.64B
| $5.8M | 0.03% |
+1,500,000
| New | +$6.15M |
2026 Q1
0 quarters
|
|
489
United Airlines
UAL
$32.1B
| $5.8M | 0.03% |
62,971
-33,829
| -35% | -$3.54M |
2025 Q2
3 quarters
|
|
490
CALL
APi Group
APG
$17.3B
| $5.79M | 0.03% |
143,000
-315,000
| -69% | -$13.4M |
2025 Q3
2 quarters
|
|
491
DigitalOcean
DOCN
$12.9B
| $5.78M | 0.03% |
67,431
+60,681
| +899% | +$3.83M |
2025 Q1
4 quarters
|
|
492
CALL
IonQ
IONQ
$12.7B
| $5.77M | 0.03% |
+200,000
| New | +$7.68M |
2026 Q1
0 quarters
|
|
|
493
PUT
IonQ
IONQ
$12.7B
| $5.77M | 0.03% |
+200,000
| New | +$7.68M |
2026 Q1
0 quarters
|
|
494
PUT
Mondelez International
MDLZ
$79.9B
| $5.76M | 0.03% |
100,000
-35,000
| -26% | -$2.03M |
2025 Q1
4 quarters
|
|
495
CALL
Alphabet (Google) Class A
GOOGL
$4.25T
| $5.75M | 0.03% |
20,000
| – | – |
2025 Q1
4 quarters
|
|
496
PUT
Akamai
AKAM
$13.2B
| $5.74M | 0.03% |
+50,000
| New | +$5.01M |
2026 Q1
0 quarters
|
|
497
PUT
ResMed
RMD
$33.1B
| $5.72M | 0.03% |
+25,500
| New | +$6.35M |
2026 Q1
0 quarters
|
|
498
CALL
DELISTED
Esperion Therapeutics
ESPR
| $5.68M | 0.03% |
2,074,000
-68,500
| -3% | -$217K |
2025 Q4
1 quarter
|
|
499
PUT
Liquidia Corp
LQDA
$3.04B
| $5.66M | 0.03% |
150,000
-39,800
| -21% | -$1.48M |
2025 Q3
2 quarters
|
|
|
500
Zoom
ZM
$27.6B
| $5.66M | 0.03% |
70,400
+965
| +1% | +$80.8K |
2025 Q4
1 quarter
|
|
Similar funds
AWM
LCIP
BPA
SA
AA
RAM
FCM
BG
Caption Management's Q1 2026 Portfolio in Review
As of Q1 2026, Caption Management held 2,194 positions worth $17.1B, up 17% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Caption Management's Q1 2026 filing shows 682 new, 333 increased, 357 reduced and 710 closed positions. Its largest new stake was Meta Platforms (Facebook): 112,500 shares worth $64.4M. The largest sale was Apple, an estimated $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 85% a quarter earlier, followed by Technology and Healthcare.
- Caption Management's largest Q1 2026 buy was Meta Platforms (Facebook): 112,500 shares worth $64.4M.
- Caption Management added most to Blue Owl Capital in Q1 2026, an estimated $166M increase.
- Caption Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $124M.
- Caption Management fully exited Apple in Q1 2026, selling an estimated $128M.
- Caption Management's ten largest holdings make up 22% of its $17.1B portfolio in Q1 2026.
- Caption Management opened 682 new positions and closed 710 in Q1 2026.
- Caption Management's portfolio value rose 17% quarter-over-quarter to $17.1B.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.